Market Value4,746,592,000
Total Holdings58
File Date2015-11-17
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
GWP / GW Pharmaceuticals plc
CLVS / Clovis Oncology Inc
TNET / TriNet Group, Inc.
BMRN / BioMarin Pharmaceutical Inc.
MARKET VECTORS ETF TR / PHARMACEUTICAL (57060U217)
AET / Aetna, Inc.
CMRX / Chimerix, Inc.
91911K102 / Bausch Health Companies
04269XAA3 / Array BioPharma Inc. Bonds 3.0% 6/1/2020
CERN / Cerner Corp.
NSTG / NanoString Technologies, Inc.
ABBV / AbbVie Inc.
SIOX / Sio Gene Therapies Inc.
PRQR / ProQR Therapeutics N.V.
GBT / Global Blood Therapeutics Inc.
SGEN / Seagen Inc
CSLT / Castlight Health Inc - Class B
DVAX / Dynavax Technologies Corporation
CCXI / ChemoCentryx Inc
CNC / Centene Corporation
ITCI / Intra-Cellular Therapies, Inc.
PGND / Press Ganey Holdings, Inc.
INCY / Incyte Corporation
GNCA / Genocea Biosciences Inc
RCPT / Receptos, Inc.
BIIB / Biogen Inc.
FLXN / Horizon Funds - Horizon Flexible Income ETF
/ Oxford Immunotec Global PLC
RARE / Ultragenyx Pharmaceutical Inc.
01449J105 / Alere Inc.
TRIV / TriVascular Technologies, Inc.
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
IRWD / Ironwood Pharmaceuticals, Inc.
INSM / Insmed Incorporated
DRRX / DURECT Corporation
KDNY / Chinook Therapeutics Inc
SRRA / Sierra Oncology Inc
MDVN / Medivation, Inc.
SESN / Sesen Bio Inc.
WCG / Wellcare Health Plans, Inc.
ADVM / Adverum Biotechnologies, Inc.
HNT / Health Net Inc.
CASC / Cascadian Therapeutics, Inc.
NXTM / NxStage Medical, Inc.
NDRM / NeuroDerm Ltd.
RAD / Rite Aid Corp.
BLCM / Bellicum Pharmaceuticals, Inc.
/ Array BioPharma, Inc.
INFI / Infinity Pharmaceuticals Inc.
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
CERS / Cerus Corporation
CFMS / Conformis Inc.
NVRO / Nevro Corp.
JAZZ / Jazz Pharmaceuticals plc
XBI / SPDR Series Trust - SPDR S&P Biotech ETF
CIVI / Civitas Resources, Inc.
SAGE / Sage Therapeutics, Inc.
IHF / iShares Trust - iShares U.S. Healthcare Providers ETF
NVTA / Invitae Corporation
MODN / Model N, Inc.
KYTH / Kythera Biopharma
ZSPH / ZS Pharma, Inc.
NLTX / Neoleukin Therapeutics, Inc.
CI / The Cigna Group
FLDM / Standard BioTools Inc
DVA / DaVita Inc.
0PP / Portola Pharmaceuticals Inc
UHS / Universal Health Services, Inc.
018490100 / Allergan plc
FATE / Fate Therapeutics, Inc.
CLDX / Celldex Therapeutics, Inc.
BPMC / Blueprint Medicines Corporation
HCA / HCA Healthcare, Inc.
PEN / Penumbra, Inc.
FOLD / Amicus Therapeutics, Inc.
RGNX / REGENXBIO Inc.
ATRA / Atara Biotherapeutics, Inc.